New partnership to develop treatment for peanut allergies

Press Releases   •   Apr 18, 2018 03:57 GMT

Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.

Yrt0foqirsyojb7wem7o Pshcwebmcn9c2m9mzemi

Chr. Hansen expands production facilities for natural colors in North America

Press Releases   •   Apr 11, 2018 06:12 GMT

As the conversion wave from synthetic to natural colors continues to rise in the US market, Chr. Hansen gears up for the future


​Chr. Hansen reports solid organic growth of 9% for the first half year

Press Releases   •   Apr 11, 2018 06:04 GMT

"We are satisfied with the progress in the first half of the year, and we maintain our overall guidance for the full year,” says CEO Cees de Jong


Chr. Hansen selects Consumer Physics to introduce cutting edge real-time feed analysis

Press Releases   •   Mar 14, 2018 13:03 GMT

Pocket size, NIR spectrometer transforms feed analysis by enabling real-time, on-farm forage analysis - Chr. Hansen equips their nutritionists and distributors first, followed by all customers.


Jørgen Erichsen, Executive Vice President, Natural Colors Division, to leave Chr. Hansen Holding A/S

Press Releases   •   Feb 02, 2018 15:11 GMT

Jørgen Erichsen, Executive Vice President of the Natural Colors Division, will leave the position as Executive Vice President effective today, 2 February 2018.


Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S

Press Releases   •   Jan 29, 2018 09:07 GMT

​EVP Christoffer Lorenzen has been appointed member of the Executive Board of Chr. Hansen Holding A/S.


Chr. Hansen off to a solid start to the year: 10% organic growth in Q1

Press Releases   •   Jan 12, 2018 07:04 GMT

Bioprotection continues to show impressive momentum


​Mauricio Graber appointed new CEO of Chr. Hansen Holding A/S

Press Releases   •   Jan 08, 2018 05:51 GMT

The Board of Directors of Chr. Hansen Holding A/S has today appointed Mauricio Graber as new Chief Executive Officer (CEO) as of 1 June 2018.


​Chr. Hansen enters into partnership with Rheolution Inc.

Press Releases   •   Nov 29, 2017 13:05 GMT

New sophisticated analytics technology helps cheesemakers increase overall value from the milk processed – Chr. Hansen obtains global distribution


​Cees de Jong will step down as CEO of Chr. Hansen Holding A/S

Press Releases   •   Nov 28, 2017 07:03 GMT

Chr. Hansen’s Chief Executive Officer Cees de Jong has informed the Company that after having led Chr. Hansen as CEO for almost 5 years, he intends to pursue a career as a non-executive director outside Chr. Hansen in due course.

Contacts 5 contacts

  • Press Contact
  • Head of Media Relations (interim)
  • +45 45 74 76 36
  • +45 20 74 28 40

About Chr. Hansen A/S

About us

Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2016/17 financial year was EUR 1,063 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.


  • Chr. Hansen A/S
  • Boege Allé 10-12
  • DK-2970 Hoersholm
  • Denmark